Tarsus Pharmaceuticals, Inc. (TARS) — Dilution Risk Analysis
Current Snapshot
Tarsus Pharmaceuticals, Inc. (TARS) has a DilutionWatch score of 14/10 and is classified as LOW risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 14/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
Recent filing forms in the source payload: 4 5, SC 13G/A 1, 8-K 3, XBRL 1.
| Form | Filed | Accession |
|---|---|---|
| 4 | 2026-09-03 | 0001827672-26-000011 |
| 4 | 2026-09-03 | 0001842190-26-000009 |
| SC 13G/A | 2026-08-13 | 0001274173-26-000207 |
| 8-K | 2026-08-06 | 0001819790-26-000060 |
| 8-K | 2026-08-06 | 0001819790-26-000062 |
| 8-K | 2026-07-08 | 0001819790-26-000046 |
| xbrl | 2026-06-30 | xbrl-2501-xbrl_warrant |
| 4 | 2026-06-29 | 0001228684-26-000008 |
| 4 | 2026-06-29 | 0001051578-26-000008 |
| 4 | 2026-06-29 | 0001181186-26-000006 |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Cash runway | 51 months | Source |
| Three-year share count growth | 32.56% | Source |
DilutionWatch Analysis
- Risk Level
- LOW (Score: 14/10) Source
- Cash Runway
- 51 months Source
- Share Count Growth (3-Year)
- 32.56% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.